Renvela
Renvela (sevelamer carbonate) is a non-calcium, non-metal phosphate binder. It works by binding dietary phosphorus in the gastrointestinal tract, which prevents its absorption into the bloodstream and helps maintain healthy phosphorus levels in patients on dialysis.
Dosage by Body Weight
Must be taken with meals. The typical starting adult dose is 0.8 g to 1.6 g orally three times daily with meals, depending on initial serum phosphorus levels. Pediatric dosing for children 6 years and older is determined by Body Surface Area (BSA). Dose titration is guided by regular blood tests.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age or in this weight range.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age or in this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age or in this weight range.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age or in this weight range.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age or in this weight range. Dosing for older pediatric patients is based on Body Surface Area (BSA), not weight alone.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in patients under 6 years of age or in this weight range. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in patients under 6 years of age or in this weight range. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in patients under 6 years of age or in this weight range. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy have not been established in patients under 6 years of age or in this weight range. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy have not been established in patients under 6 years of age or in this weight range. Dosing for older pediatric patients is based on Body Surface Area (BSA), not weight alone. |
Formulation
Purpose
Used to control phosphorus levels in adults and children aged 6 years and older with chronic kidney disease (CKD) on dialysis.
Generic Name
Sevelamer carbonateScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.